We are investigating a new treatment combining Avelumab and Methotrexate for individuals with low-risk gestational trophoblastic neoplasias. This study aims to see if this combination is a safe and effective first-line option.
Health conditions and diseases that the clinical trial is designed to study and treat.
Gestational trophoblastic tumor is a rare type of tumor that develops from the cells that would normally form the placenta during pregnancy. It can lead to abnormal growth and requires careful monitoring and treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.